Society for Immunotherapy of Cancer (SITC), shared on LinkedIn:
“Explore the investment trends driving the next generation of immuno-oncology innovation.
Join the Session VII: Investment Panel at the 2026 SITC EU Immuno-Oncology Drug Development Summit to hear expert perspectives on advancing breakthrough therapies.
Other articles about Immunotherapy on OncoDaily.